A 3-month-old with sepsis

Infections in Medicine

Volumn 16, Issue 5, 1999, Pages 311-316

  Mato, Sayonara Perez ^a,b   Stamm, Walter E ^c   Begue, Rodolfo E ^a,d  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d LSU School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPLENIA; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE PREDISPOSITION; FEMALE; HUMAN; INFANT; MENINGITIS; REINFECTION; RELAPSE; SEPSIS; STREPTOCOCCUS PNEUMONIAE; TREATMENT PLANNING;

EID: 2442770035     PISSN: 07496524     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. Ferlicot S, Emile JF, Le Bris, et al: Congenital asplenia. A childhood immune deficit often detected too late. Annales de Pathologie 17:44-46, 1997.
2. Waldman JD, Rosenthal A, Smith AL, et al: Sepsis and congenital asplenia. J Pediatr 90:555-559, 1997.
3. Sills RH: Splenic function: Physiology and splenic hypofunction. Crit Rev Oncol Hematol 7:1-36, 1987.
4. Wang JK, Hsieh KH: Immunologic study of the asplenia syndrome. Pediatr Infect Dis J 10:819-822, 1991.
5. Jones KL: Smith's Recognizable Patterns of Human Malformation, ed 5, Philadelphia, Pa., W.B. Saunders Company, 1997, pp 602-603.
6. Corazza GR, Ginaldi L, Zoli G, et al: Howell-Jolly body counting as a measure of splenic function. A reassessment. Clin Lab Haematol 12:269-275, 1990.
7. Webber SA, Sandor GG, Patterson MW, et al: Immunogenicity of Haemophilus influenzae type b conjugate vaccine in children with congenital asplenia. J Infect Dis 167:1210-1212, 1993.
8. McElroy PJ, Henderson FI, Brown DL: Immune status and response to immunization with polysaccharide vaccines of a healthy, congenitally asplenic woman. Clin Exp Immunol 78:402-405, 1989.
9. Rennels MB, Edwards KM, Keyserling HL, et al: Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM197 in United States infants. Pediatrics 101:604-611, 1998.
10. Butler JC: Epidemiology of pneumococcal serotypes and conjugate vaccine formulations. Microbiol Drug Resistance 3:125-129.
11. Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 46(RR-8):1-24, 1997.
12. Sorensen RU, Leiva LE, Giangrosso PA, et al: Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 17:685-691, 1998.
13. Black S, Shinefield H, Ray P, et al: Efficacy of heptavalent conjugate pneumococcal vaccine (Wyeth Lederle) in 37,000 infants and children: Results of the northern California Kaiser Permanente efficacy trial. Abstracts of the 38th ICAAC, September 24-27, 1998, San Diego, California.